Marketplace · Netherlands
Pharmacies businesses in Amersfoort typically transact at 5.2x–7.8x EV/EBITDA, with a sector median of 6.4x in the Netherlands. Central Netherlands growth city and IT-services hub.
Amersfoort (population ~160,000, Utrecht Province) anchors pharmacies transactions at a 6.4x EV/EBITDA median, with most defensible deals landing between 5.2x (conservative) and 7.8x (strong recurring revenue). Central Netherlands growth city and IT-services hub. SMEs concentrate in software, consulting, logistics and B2B services; central location and talent density drive strong mid-market deal flow.
Upswitch is anonymity-by-design — new pharmacies dossiers in Amersfoort surface here as soon as they pass advisor validation. Subscribe to the alert and we'll notify you within hours of the next listing going live.
Browse all listingsFor a pharmacies SME in Amersfoort with normalised EBITDA above €200k, expect the headline price to anchor on a 6.4x EV/EBITDA multiple, with a working-capital peg, 5–15% escrow, and (in 35–45% of deals) an earn-out tied to year-one EBITDA or customer retention. Cross-border buyer interest from Belgian acquirers is consistently elevated.
Central Netherlands growth city and IT-services hub. SMEs concentrate in software, consulting, logistics and B2B services; central location and talent density drive strong mid-market deal flow. For pharmacies specifically, Amersfoort's buyer pool typically includes regional family businesses, Benelux-wide strategic acquirers, and (for deals above ~€2m EV) PE-backed roll-up platforms.